Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress
- PMID: 25958314
- PMCID: PMC4522350
- DOI: 10.1016/j.jpain.2015.04.007
Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress
Abstract
Omega-3 and omega-6 fatty acids are biosynthetic precursors of endocannabinoids with antinociceptive, anxiolytic, and neurogenic properties. We recently reported that targeted dietary manipulation-increasing omega-3 fatty acids while reducing omega-6 linoleic acid (the H3-L6 intervention)-reduced headache pain and psychological distress among chronic headache patients. It is not yet known whether these clinical improvements were due to changes in endocannabinoids and related mediators derived from omega-3 and omega-6 fatty acids. We therefore used data from this trial (N = 55) to investigate 1) whether the H3-L6 intervention altered omega-3- and omega-6-derived endocannabinoids in plasma and 2) whether diet-induced changes in these bioactive lipids were associated with clinical improvements. The H3-L6 intervention significantly increased the omega-3 docosahexaenoic acid derivatives 2-docosahexaenoylglycerol (+65%, P < .001) and docosahexaenoylethanolamine (+99%, P < .001) and reduced the omega-6 arachidonic acid derivative 2-arachidonoylglycerol (-25%, P = .001). Diet-induced changes in these endocannabinoid derivatives of omega-3 docosahexaenoic acid, but not omega-6 arachidonic acid, correlated with reductions in physical pain and psychological distress. These findings demonstrate that targeted dietary manipulation can alter endocannabinoids derived from omega-3 and omega-6 fatty acids in humans and suggest that 2-docosahexaenoylglycerol and docosahexaenoylethanolamine could have physical and/or psychological pain modulating properties.
Trial registration: ClinicalTrials.gov (NCT01157208) PERSPECTIVE: This article demonstrates that targeted dietary manipulation can alter endocannabinoids derived from omega-3 and omega-6 fatty acids and that these changes are related to reductions in headache pain and psychological distress. These findings suggest that dietary interventions could provide an effective, complementary approach for managing chronic pain and related conditions.
Keywords: 2-arachidonoylglycerol; 2-docosahexaenoylglycerol; Endocannabinoids; docosahexaenoylethanolamine; headache; psychological distress.
Published by Elsevier Inc.
Conflict of interest statement
Figures
Similar articles
-
Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache: a secondary analysis of a randomized trial.Pain. 2015 Apr;156(4):587-596. doi: 10.1097/01.j.pain.0000460348.84965.47. Pain. 2015. PMID: 25790451 Free PMC article. Clinical Trial.
-
Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial.BMJ. 2021 Jun 30;374:n1448. doi: 10.1136/bmj.n1448. BMJ. 2021. PMID: 34526307 Free PMC article. Clinical Trial.
-
Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial.Pain. 2013 Nov;154(11):2441-2451. doi: 10.1016/j.pain.2013.07.028. Epub 2013 Jul 22. Pain. 2013. PMID: 23886520 Free PMC article. Clinical Trial.
-
Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and Repair.Lipids. 2017 Nov;52(11):885-900. doi: 10.1007/s11745-017-4292-8. Epub 2017 Sep 5. Lipids. 2017. PMID: 28875399 Free PMC article. Review.
-
ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer.Nutrients. 2020 Sep 10;12(9):2751. doi: 10.3390/nu12092751. Nutrients. 2020. PMID: 32927614 Free PMC article. Review.
Cited by
-
Ratio of Omega-6/Omega-3 Polyunsaturated Fatty Acids Associated With Somatic and Depressive Symptoms in People With Painful Temporomandibular Disorder and Irritable Bowel Syndrome.J Pain. 2022 Oct;23(10):1737-1748. doi: 10.1016/j.jpain.2022.04.006. Epub 2022 Apr 25. J Pain. 2022. PMID: 35477107 Free PMC article.
-
Excessive dietary linoleic acid promotes plasma accumulation of pronociceptive fatty acyl lipid mediators.Sci Rep. 2022 Oct 25;12(1):17832. doi: 10.1038/s41598-022-21823-y. Sci Rep. 2022. PMID: 36284115 Free PMC article.
-
Tetracosahexaenoylethanolamide, a novel N-acylethanolamide, is elevated in ischemia and increases neuronal output.J Lipid Res. 2020 Nov;61(11):1480-1490. doi: 10.1194/jlr.RA120001024. Epub 2020 Aug 21. J Lipid Res. 2020. PMID: 32826272 Free PMC article.
-
Inverse Association between Dietary Diversity Score Calculated from the Diet Quality Questionnaire and Psychological Stress in Chinese Adults: A Prospective Study from China Health and Nutrition Survey.Nutrients. 2022 Aug 12;14(16):3297. doi: 10.3390/nu14163297. Nutrients. 2022. PMID: 36014804 Free PMC article.
-
Transmission of risk from parents with chronic pain to offspring: an integrative conceptual model.Pain. 2016 Dec;157(12):2628-2639. doi: 10.1097/j.pain.0000000000000637. Pain. 2016. PMID: 27380502 Free PMC article. Review.
References
-
- Almeida-Santos AF, Gobira PH, Rosa LC, Guimaraes FS, Moreira FA, Aguiar DC. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray. Behavioural brain research. 2013;252:10–17. - PubMed
-
- Antonova M, Wienecke T, Olesen J, Ashina M. Prostaglandin E(2) induces immediate migraine-like attack in migraine patients without aura. Cephalalgia: an international journal of headache. 2012;32:822–833. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- Z99 AA999999/ImNIH/Intramural NIH HHS/United States
- T32 AT003378/AT/NCCIH NIH HHS/United States
- UL1 TR002489/TR/NCATS NIH HHS/United States
- R01 DA007215/DA/NIDA NIH HHS/United States
- T32-AT003378/AT/NCCIH NIH HHS/United States
- P01 DA009158/DA/NIDA NIH HHS/United States
- DK056350/DK/NIDDK NIH HHS/United States
- DA09158/DA/NIDA NIH HHS/United States
- UL1 TR001111/TR/NCATS NIH HHS/United States
- DA07215/DA/NIDA NIH HHS/United States
- UL1RR025747/RR/NCRR NIH HHS/United States
- P30 DK056350/DK/NIDDK NIH HHS/United States
- UL1 RR025747/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical